HUTCHMED (China) Ltd (HCM)

Industry Drug Manufacturers - Specialty & Generic

This stock can be held in an Investment ISA, SIPP and Investment Account

Sell

222.00p

Buy

225.00p

arrow-down-5.00p (-2.20%)

Prices updated at 13 Nov 2026, 16:35 GMT

Prices minimum 15 mins delay

Prices in GBX

HUTCHMED (China) Ltd is a biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several c ...

FTSE All-Share

0.27%

LSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

our Investment Fees and Charges.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Chairman

Dr. Dan Eldar

CEO

Mr. Johnny Cheng Chig FUNG

Most recent earnings

31 Dec 2025

Fiscal year end

31 Dec 2025

Employees

1,796

Head office

2 Queen's Road Central

Hong Kong

+852 2121 8200

ir@chi-med.com

Company website

Key personnel

Owner name chevron-l-regular chevron-r-regular	Salary
Dr. Renu Bhatia Non-Executive Director, Senior Independent Director	-
Ms. Edith Shih, C.A.,M.A.,M.B.A. Non-Executive Director, Company Secretary	-
Dr. Dan Eldar Non-Executive Director, Chairman	-
Mr. Johnny Cheng Chig FUNG Executive Director, Acting Chief Executive Officer and Chief Financial Officer	-

Top 5 shareholders

Owner name chevron-l-regular chevron-r-regular	No. of shares
China Universal Asset Mgmt Co.Ltd	21,195,000
China Universal CNI HK Eq Cn Innv Dg ETF	20,102,000
GF Fund Mgmt Co.,Ltd	15,919,900
GF CSI Hong Kong Brand Nm Drug ETF(QDII)	15,885,000
Vanguard	13,669,883

Director dealings

Date chevron-l-regular chevron-r-regular	Action
13 Mar 2026	Transfer in
10 Mar 2026	Transfer in
10 Mar 2026	Transfer in

Please note that past performance is not a reliable indicator of future returns.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser.

© Copyright 2026 Morningstar. All rights reserved. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.

The ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar accepts no responsibility or liability whatsoever for the actions of third parties in this respect.